SLC6A3 and attention deficit-hyperactivity disorder: The importance of dat-1 epigenetics in the prognosis of ADHD was also demonstrated in a clinical study showing that the methylation status in the promoter region of dat-1 can predict the treatment outcomes of ADHD with methylphenidate, particularly on oppositional and hyperactive-impulsive symptoms [29].